Vol. 57 No. s4 (2005)

Articles

• Are there differences among anti-TNFa biological drugs?

  G. Valesini

  1-2

  https://doi.org/10.4081/reumatismo.2005.4s.1

  Published:

  729

  PDF: 568

  • PDF

• Effects of TNF antagonists on immune and neuroendocrine system

  G. Valesini, M. Cutolo

  3-7

  https://doi.org/10.4081/reumatismo.2005.4s.3

  Published:

  1113

  PDF: 722

  • PDF

• Differences in pharmacology of tumor necrosis factor (TNF) antagonists

  U. Fiocco, S. Bombardieri

  8-16

  https://doi.org/10.4081/reumatismo.2005.4s.8

  Published:

  1099

  PDF: 1732

  • PDF

• Biologic therapy with anti-TNFa in rheumathoid atrhritis

  G. Ferraccioli

  17-21

  https://doi.org/10.4081/reumatismo.2005.4s.17

  Published:

  731

  PDF: 653

  • PDF

• Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

  G. Lapadula

  22-29

  https://doi.org/10.4081/reumatismo.2005.4s.22

  Published:

  748

  PDF: 1055

  • PDF

• Approved indications and other possible utilizations of anti-TNFa biologic drugs

  W. Grassi, C. Montecucco

  30-33

  https://doi.org/10.4081/reumatismo.2005.4s.30

  Published:

  1107

  PDF: 862

  • PDF

• Safety of anti-TNFa biological drugs

  F. Trotta, G. Valentini

  34-39

  https://doi.org/10.4081/reumatismo.2005.4s.34

  Published:

  1104

  PDF: 1097

  • PDF